Jim Simons Cidara Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$0.64 - $0.92 $481,792 - $692,576
752,800 Added 41.77%
2,554,973 $2.35 Million
Q4 2023

Feb 13, 2024
BUY
$0.68 - $0.97 $137,700 - $196,425
202,500 Added 12.66%
1,802,173 $1.43 Million
Q3 2023

Nov 14, 2023
BUY
$0.77 - $1.16 $38,577 - $58,115
50,100 Added 3.23%
1,599,673 $1.51 Million
Q2 2023

Aug 11, 2023
BUY
$1.01 - $1.42 $295,728 - $415,776
292,800 Added 23.3%
1,549,573 $1.75 Million
Q1 2023

May 12, 2023
BUY
$0.75 - $1.98 $53,550 - $141,372
71,400 Added 6.02%
1,256,773 $1.6 Million
Q4 2022

Feb 13, 2023
SELL
$0.48 - $13.08 $51,792 - $1.41 Million
-107,900 Reduced 8.34%
1,185,373 $896,000
Q3 2022

Nov 14, 2022
BUY
$0.45 - $13.0 $61,657 - $1.78 Million
137,016 Added 11.85%
1,293,273 $812,000
Q2 2022

Aug 12, 2022
SELL
$0.43 - $0.91 $121,082 - $256,245
-281,588 Reduced 19.58%
1,156,257 $565,000
Q1 2022

May 13, 2022
BUY
$0.67 - $1.39 $15,803 - $32,787
23,588 Added 1.67%
1,437,845 $1.2 Million
Q4 2021

Feb 11, 2022
BUY
$1.18 - $2.18 $346,915 - $640,911
293,996 Added 26.24%
1,414,257 $1.8 Million
Q3 2021

Nov 12, 2021
BUY
$1.48 - $2.35 $109,457 - $173,801
73,958 Added 7.07%
1,120,261 $2.51 Million
Q2 2021

Aug 13, 2021
BUY
$1.87 - $2.7 $444,686 - $642,060
237,800 Added 29.41%
1,046,303 $2.11 Million
Q1 2021

May 13, 2021
SELL
$2.06 - $3.01 $1.55 Million - $2.26 Million
-751,151 Reduced 48.16%
808,503 $2.15 Million
Q4 2020

Feb 10, 2021
BUY
$1.99 - $3.25 $606,858 - $991,100
304,954 Added 24.3%
1,559,654 $3.12 Million
Q3 2020

Nov 13, 2020
BUY
$2.85 - $4.1 $299,711 - $431,164
105,162 Added 9.15%
1,254,700 $3.58 Million
Q2 2020

Aug 13, 2020
BUY
$2.39 - $4.0 $511,314 - $855,756
213,939 Added 22.87%
1,149,538 $4.24 Million
Q1 2020

May 14, 2020
BUY
$1.74 - $4.26 $243,497 - $596,148
139,941 Added 17.59%
935,599 $2.32 Million
Q4 2019

Feb 13, 2020
BUY
$1.77 - $3.84 $212,346 - $460,684
119,970 Added 17.76%
795,658 $3.06 Million
Q3 2019

Nov 13, 2019
BUY
$1.25 - $2.35 $81,182 - $152,623
64,946 Added 10.63%
675,688 $1.35 Million
Q2 2019

Aug 12, 2019
BUY
$1.49 - $2.94 $318,874 - $629,189
214,010 Added 53.94%
610,742 $1.03 Million
Q1 2019

May 14, 2019
BUY
$2.35 - $3.27 $188,545 - $262,358
80,232 Added 25.35%
396,732 $1.05 Million
Q4 2018

Feb 13, 2019
BUY
$2.1 - $4.5 $664,650 - $1.42 Million
316,500 New
316,500 $744,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.43B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email